| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | The Quipt deal is good for shareholders, Leede says | 1 | Cantech Letter | ||
| 16.12. | Quipt Home Medical stock to be acquired by Kingswood and Forager for $3.65 per share | 2 | Investing.com | ||
| 15.12. | Quipt Home Medical Corp: Quipt signs deal for acquisition by Kingswood, Forager | 1 | Stockwatch | ||
| 15.12. | Stocks in Play: Quipt Home Medical Corp. | 3 | Baystreet.ca | ||
| QUIPT HOME MEDICAL Aktie jetzt für 0€ handeln | |||||
| 15.12. | Quipt Home Medical stock downgraded to Sell by Stifel on acquisition news | 2 | Investing.com | ||
| 15.12. | Quipt Home Medical GAAP EPS of -$0.08, revenue of $68.3M | 2 | Seeking Alpha | ||
| 15.12. | Quipt Home Medical Corp.: Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management | 175 | GlobeNewswire (Europe) | Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's... ► Artikel lesen | |
| 15.12. | Quipt Home Medical Corp. - 10-K, Annual Report | - | SEC Filings | ||
| 15.12. | Quipt Home Medical Corp. - 8-K, Current Report | - | SEC Filings | ||
| 05.12. | Quipt Home Medical holder urgers board to pursue a sale | 2 | Seeking Alpha | ||
| 22.10. | Lakeview Investment Group urges Quipt to engage with bidder | 1 | Investing.com | ||
| 11.09. | Quipt Home Medical Corp: Quipt holder/suitor Forager highlights premium in offer | 3 | Stockwatch | ||
| 04.09. | Quipt Home Medical Corp: Quipt holder/suitor Forager rips "self-serving" board | 5 | Stockwatch | ||
| 03.09. | Quipt Home Medical Corp: Quipt closes acquisition of 60% of Hart | 2 | Stockwatch | ||
| 03.09. | Quipt Home Medical completes strategic acquisition of Hart Medical for $17.4M | 2 | Seeking Alpha | ||
| 03.09. | Quipt Home Medical Corp.: Quipt Home Medical Completes Strategic Acquisition of Hart Medical Adding $60 Million in Revenue | 317 | GlobeNewswire (Europe) | CINCINNATI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 27.08. | Quipt Home Medical Corp: Quipt receives another unsolicited offer from Forager | 1 | Stockwatch | ||
| 27.08. | Stocks in Play: Quipt Home Medical Corp. | 3 | Baystreet.ca | ||
| 27.08. | Quipt Home Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.08. | Quipt Home Medical confirms receipt of Forager's 'undervalued offer' | 2 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,710 | -0,22 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FAMICORD | 5,950 | -2,46 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| M1 KLINIKEN | 17,860 | +0,34 % | M1 Kliniken: Zimmnau in den Vorstand berufen | M1 Kliniken erweitert den Vorstand: Einer Meldung des Berliner Unternehmens vom Donnerstag zufolge hat man "Katharina Zimmnau mit Wirkung zum 10.12.2025 in den Vorstand der M1 Kliniken AG berufen".... ► Artikel lesen | |
| BAXTER | 16,106 | +0,27 % | Baxter International schließt finalen Anleihenrückkauf ab | ||
| MEDICLIN | 3,560 | -1,66 % | EQS-News: MEDICLIN AG: Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025 | EQS-News: MEDICLIN AG
/ Schlagwort(e): Personalie
Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025
16.12.2025 / 15:00 CET/CEST
Für... ► Artikel lesen | |
| DAVITA | 97,82 | +0,53 % | DaVita: Balancing a Kidney Diet: Optimizing Nutrition Through Personalization | NORTHAMPTON, MA / ACCESS Newswire / December 22, 2025 / DaVita:For individuals managing chronic kidney disease (CKD), dietary choices significantly impact health outcomes and disease progression. A... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,210 | 0,00 % | Co-Diagnostics Reports Third Quarter 2025 Financial Results | SALT LAKE CITY, Nov. 13, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company... ► Artikel lesen | |
| CYTOSORBENTS | 0,622 | +3,84 % | Cytosorbents Corp: CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update | Third quarter 2025 revenue of $9.5 million, up 10% year-over-year
Amended credit agreement with Avenue Capital Group which strengthens our balance sheet... ► Artikel lesen | |
| LIMES SCHLOSSKLINIKEN | 344,00 | -2,27 % | EQS-DD: Limes Schlosskliniken AG: GMF Capital GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
18.12.2025 / 11:21... ► Artikel lesen | |
| SENSEONICS | 5,350 | +1,90 % | XFRA 6L60: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| VIROMED MEDICAL | 3,560 | -0,56 % | Viromed Medical AG: Innovative Medizintechnologie als Antwort auf globale Antibiotikaresistenzen | ||
| UNIVERSAL HEALTH SERVICES | 192,00 | -0,52 % | Universal Health Services stock price target reiterated at $250 by Cantor Fitzgerald | ||
| BIOCEPT | - | - | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| DELCATH SYSTEMS | 8,700 | +1,16 % | Delcath Systems, Inc.: Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress | Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the acceptance of an oral presentation on... ► Artikel lesen |